Molecule Details
InChIKeyRONZAEMNMFQXRA-UHFFFAOYSA-N
Compound NameMirtazapine
Canonical SMILESCN1CCN2c3ncccc3Cc3ccccc3C2C1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)9
Pfam Stratification Homologous
Avg pChEMBL7.58
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00370
Drug NameMirtazapine
CAS Number85650-52-8
Groups approved investigational
ATC Codes N06AX11
DescriptionMirtazapine is a tetracyclic _piperazino-azepine_ antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.[A177946] This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major ...

Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic alpha-2 Receptor Antagonists Adrenergic alpha-Antagonists Agents that produce hypertension Anti-Anxiety Agents Antidepressive Agents Antidepressive Agents Indicated for Depression Antidepressive Agents, Second-Generation Antidepressive Agents, Tetracyclic Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Heterocyclic Compounds, Fused-Ring Histamine Agents Histamine Antagonists Histamine H1 Antagonists Miscellaneous Antidepressants Nervous System Neurotransmitter Agents Potential QTc-Prolonging Agents Psychoanaleptics Psychotropic Drugs QTc Prolonging Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT2 Receptor Antagonists Serotonin 5-HT2A Receptor Antagonists Serotonin 5-HT2C Receptor Antagonists Serotonin 5-HT3 Receptor Antagonists Serotonin Agents Serotonin Modulators Serotonin Receptor Antagonists Tranquilizing Agents
Cross-references: BindingDB: 50115644 ChEBI: 6950 CHEMBL654 ChemSpider: 4060 Drugs Product Database (DPD): 12209 C07570 D00563 PharmGKB: PA450522 PubChem:4205 PubChem:46506965 RxCUI: 15996 Therapeutic Targets Database: DAP000010 Wikipedia: Mirtazapine
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
P35348 ADRA1A Homo sapiens Human PF00001 8.8 pIC50 TTD_MultiTarget
P35367 HRH1 Homo sapiens Human PF00001 8.8 Ki ChEMBL;BindingDB
P08908 HTR1A Homo sapiens Human PF00001 7.7 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P28335 HTR2C Homo sapiens Human PF00001 7.4 Ki ChEMBL;BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 7.4 IC50 ChEMBL;BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 7.2 IC50 ChEMBL;BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 6.7 IC50 ChEMBL;BindingDB
P34969 HTR7 Homo sapiens Human PF00001 6.6 Ki ChEMBL;BindingDB
DrugBank Target Actions (13)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P41145 OPRK1 Kappa-type opioid receptor agonist targets
P08913 ADRA2A Alpha-2A adrenergic receptor antagonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A antagonist targets
P28335 HTR2C 5-hydroxytryptamine receptor 2C antagonist targets
P35348 ADRA1A Alpha-1 adrenergic receptors antagonist targets
P35367 HRH1 Histamine H1 receptor antagonist targets
Q9UE69 Q9UE69 5HT3 serotonin receptor antagonist targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor transporters
P31645 SLC6A4 Sodium-dependent serotonin transporter substrate transporters